Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 1,633 | 2,194 | 1,874 | 2,519 | 2,188 |
| Operating Income | -1,633 | -2,194 | -1,874 | -2,519 | -2,188 |
| Other Income | 0 | 0 | 0 | 0 | 3 |
| Pre-tax Income | -1,634 | -2,194 | -1,874 | -2,519 | -2,185 |
| Net Income Continuous | -1,634 | -2,194 | -1,874 | -2,519 | -2,185 |
| Net Income | $-1,634 | $-2,194 | $-1,874 | $-2,519 | $-2,185 |
| EPS Basic Total Ops | -1.08 | 0.79 | -10.81 | -11.64 | -14.58 |
| EPS Basic Continuous Ops | -1.08 | 6.01 | -5.98 | -11.65 | -14.58 |
| EPS Diluted Total Ops | -1.08 | 0.79 | -10.81 | -11.64 | -14.58 |
| EPS Diluted Continuous Ops | -1.08 | 6.01 | -5.98 | -11.65 | -14.58 |
| EPS Diluted Before Non-Recurring Items | -1.08 | N/A | -10.81 | -11.65 | -14.65 |
| EBITDA(a) | $-1,596 | $-2,154 | $-1,834 | $-2,479 | $-2,107 |